Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States
Author:
Affiliation:
1. The Scripps Research Institute, La Jolla, CA, and Molsoft, LLC, La Jolla, CA
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm8010299
Reference49 articles.
1. The Protein Kinase Complement of the Human Genome
2. Protein kinases — the major drug targets of the twenty-first century?
3. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding
4. Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
5. Design and Discovery of Small Molecules Targeting Raf-1 Kinase
Cited by 170 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy;Medicine in Drug Discovery;2024-09
2. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11
3. A Bioinformatic Analysis Predicts That Cannabidiol Could Function as a Potential Inhibitor of the MAPK Pathway in Colorectal Cancer;Current Issues in Molecular Biology;2024-08-05
4. A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures;PLOS Computational Biology;2024-07-24
5. The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinases;Leukemia & Lymphoma;2024-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3